• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在缺乏诱导性共刺激分子的情况下,调节性T细胞反应受损,动脉粥样硬化加剧。

Impaired regulatory T-cell response and enhanced atherosclerosis in the absence of inducible costimulatory molecule.

作者信息

Gotsman Israel, Grabie Nir, Gupta Rajat, Dacosta Rosa, MacConmara Malcolm, Lederer James, Sukhova Galina, Witztum Joseph L, Sharpe Arlene H, Lichtman Andrew H

机构信息

Immunology Division, Brigham and Women's Hospital, and Harvard Medical School, Boston, Mass 02115, USA.

出版信息

Circulation. 2006 Nov 7;114(19):2047-55. doi: 10.1161/CIRCULATIONAHA.106.633263. Epub 2006 Oct 23.

DOI:10.1161/CIRCULATIONAHA.106.633263
PMID:17060381
Abstract

BACKGROUND

T-cell-mediated immunity contributes to the pathogenesis of atherosclerosis, but little is known about how these responses are regulated. We explored the influence of the inducible costimulatory molecule (ICOS) on atherosclerosis and associated immune responses.

METHODS AND RESULTS

Bone marrow chimeras were generated by transplanting ICOS-deficient or wild-type bone marrow into irradiated atherosclerosis-prone, LDR receptor-deficient mice, and the chimeric mice were fed a high-cholesterol diet for 8 weeks. Compared with controls, mice transplanted with ICOS-deficient marrow had a 43% increase in the atherosclerotic burden, and importantly, their lesions had a 3-fold increase in CD4+ T cells, as well as increased macrophage, smooth muscle cell, and collagen content. CD4+ T cells from ICOS-deficient chimeras proliferated more and secreted more interferon-gamma and tumor necrosis factor-alpha than T cells from control mice, which suggests a lack of regulation. FoxP3+ regulatory T cells (Treg) were found to constitutively express high ICOS levels, which suggests a role for ICOS in Treg function. ICOS-deficient mice had decreased numbers of FoxP3+ Treg and impaired in vitro Treg suppressive function compared with control mice.

CONCLUSIONS

ICOS has a key role in regulation of atherosclerosis, through its effect on regulatory T-cell responses.

摘要

背景

T细胞介导的免疫反应参与动脉粥样硬化的发病机制,但对于这些反应如何被调节却知之甚少。我们探讨了诱导性共刺激分子(ICOS)对动脉粥样硬化及相关免疫反应的影响。

方法与结果

通过将ICOS缺陷型或野生型骨髓移植到经辐射的易患动脉粥样硬化、低密度脂蛋白受体缺陷型小鼠体内,构建骨髓嵌合体小鼠,并给予这些嵌合体小鼠高胆固醇饮食8周。与对照组相比,移植了ICOS缺陷型骨髓的小鼠动脉粥样硬化负担增加了43%,重要的是,其病变部位的CD4+ T细胞增加了3倍,同时巨噬细胞、平滑肌细胞和胶原蛋白含量也增加。与对照组小鼠的T细胞相比,来自ICOS缺陷型嵌合体小鼠的CD4+ T细胞增殖更多,分泌的干扰素-γ和肿瘤坏死因子-α也更多,这表明缺乏调节。发现FoxP3+调节性T细胞(Treg)组成性地高表达ICOS,这表明ICOS在Treg功能中发挥作用。与对照组小鼠相比,ICOS缺陷型小鼠的FoxP3+ Treg数量减少,体外Treg抑制功能受损。

结论

ICOS通过对调节性T细胞反应的影响,在动脉粥样硬化的调节中起关键作用。

相似文献

1
Impaired regulatory T-cell response and enhanced atherosclerosis in the absence of inducible costimulatory molecule.在缺乏诱导性共刺激分子的情况下,调节性T细胞反应受损,动脉粥样硬化加剧。
Circulation. 2006 Nov 7;114(19):2047-55. doi: 10.1161/CIRCULATIONAHA.106.633263. Epub 2006 Oct 23.
2
A functional role for inducible costimulator (ICOS) in atherosclerosis.诱导性共刺激分子(ICOS)在动脉粥样硬化中的功能作用。
Atherosclerosis. 2005 Nov;183(1):57-63. doi: 10.1016/j.atherosclerosis.2005.03.040. Epub 2005 Jun 6.
3
Differential CD28 and inducible costimulatory molecule signaling requirements for protective CD4+ T-cell-mediated immunity against genital tract Chlamydia trachomatis infection.针对生殖道沙眼衣原体感染的保护性CD4 + T细胞介导免疫的差异性CD28和诱导性共刺激分子信号需求
Infect Immun. 2007 Sep;75(9):4638-47. doi: 10.1128/IAI.00465-07. Epub 2007 Jul 16.
4
Inducible costimulator (ICOS) is a marker for highly suppressive antigen-specific T cells sharing features of TH17/TH1 and regulatory T cells.诱导共刺激分子(ICOS)是一种高抑制性抗原特异性 T 细胞的标志物,其具有 TH17/TH1 和调节性 T 细胞的特征。
J Allergy Clin Immunol. 2010 Aug;126(2):280-9, 289.e1-7. doi: 10.1016/j.jaci.2010.05.022. Epub 2010 Jul 10.
5
CD4+ICOS+ T lymphocytes inhibit T cell activation 'in vitro' and attenuate autoimmune encephalitis 'in vivo'.CD4+ICOS+ T淋巴细胞在体外抑制T细胞活化,在体内减轻自身免疫性脑脊髓炎。
Int Immunol. 2008 Apr;20(4):577-89. doi: 10.1093/intimm/dxn016. Epub 2008 Feb 28.
6
Expression of ICOS on human melanoma-infiltrating CD4+CD25highFoxp3+ T regulatory cells: implications and impact on tumor-mediated immune suppression.人黑色素瘤浸润性CD4+CD25高表达Foxp3+调节性T细胞上诱导共刺激分子(ICOS)的表达:对肿瘤介导的免疫抑制的影响
J Immunol. 2008 Mar 1;180(5):2967-80. doi: 10.4049/jimmunol.180.5.2967.
7
Constitutive GITR Activation Reduces Atherosclerosis by Promoting Regulatory CD4+ T-Cell Responses-Brief Report.组成性GITR激活通过促进调节性CD4 + T细胞反应减轻动脉粥样硬化——简要报告
Arterioscler Thromb Vasc Biol. 2016 Sep;36(9):1748-52. doi: 10.1161/ATVBAHA.116.307354. Epub 2016 Jul 21.
8
CD4⁺Foxp3⁺ Treg and its ICOS⁺ subsets in patients with myocardial infarction.心肌梗死患者中的CD4⁺Foxp3⁺调节性T细胞及其ICOS⁺亚群
Iran J Immunol. 2012 Mar;9(1):53-60.
9
Defective leptin/leptin receptor signaling improves regulatory T cell immune response and protects mice from atherosclerosis.瘦素/瘦素受体信号传导缺陷可改善调节性T细胞免疫反应,并保护小鼠免受动脉粥样硬化的影响。
Arterioscler Thromb Vasc Biol. 2007 Dec;27(12):2691-8. doi: 10.1161/ATVBAHA.107.149567. Epub 2007 Aug 9.
10
Th1-Like ICOS+ Foxp3+ Treg Cells Preferentially Express CXCR3 and Home to β-Islets during Pre-Diabetes in BDC2.5 NOD Mice.在BDC2.5 NOD小鼠糖尿病前期,类似Th1的ICOS⁺ Foxp3⁺调节性T细胞优先表达CXCR3并归巢至β胰岛。
PLoS One. 2015 May 6;10(5):e0126311. doi: 10.1371/journal.pone.0126311. eCollection 2015.

引用本文的文献

1
Immune Checkpoints Are New Therapeutic Targets in Regulating Cardio-, and Cerebro-Vascular Diseases and CD4Foxp3 Regulatory T Cell Immunosuppression.免疫检查点是调节心脑血管疾病和CD4Foxp3调节性T细胞免疫抑制的新治疗靶点。
Int J Drug Discov Pharm. 2024 Dec;3(4). doi: 10.53941/ijddp.2024.100022. Epub 2024 Nov 26.
2
Local adaptive immunity in atherosclerosis with T cell activation by aortic dendritic cells accelerates pathogenesis.主动脉树突状细胞激活T细胞,引发动脉粥样硬化中的局部适应性免疫,加速疾病进展。
iScience. 2024 Oct 10;27(11):111144. doi: 10.1016/j.isci.2024.111144. eCollection 2024 Nov 15.
3
Costimulatory and Coinhibitory Immune Checkpoints in Atherosclerosis: Therapeutic Targets in Atherosclerosis?
动脉粥样硬化中的共刺激和共抑制免疫检查点:动脉粥样硬化的治疗靶点?
JACC Basic Transl Sci. 2024 Mar 13;9(6):827-843. doi: 10.1016/j.jacbts.2023.12.007. eCollection 2024 Jun.
4
T-Cell/B-Cell Interactions in Atherosclerosis.T 细胞/B 细胞在动脉粥样硬化中的相互作用。
Arterioscler Thromb Vasc Biol. 2024 Jul;44(7):1502-1511. doi: 10.1161/ATVBAHA.124.319845. Epub 2024 May 30.
5
Targeting regulatory T cells for cardiovascular diseases.靶向调节性 T 细胞治疗心血管疾病。
Front Immunol. 2023 Feb 23;14:1126761. doi: 10.3389/fimmu.2023.1126761. eCollection 2023.
6
Atherosclerosis With Immune Checkpoint Inhibitor Therapy: Evidence, Diagnosis, and Management: State-of-the-Art Review.免疫检查点抑制剂治疗相关动脉粥样硬化:证据、诊断与管理:最新综述
JACC CardioOncol. 2022 Dec 20;4(5):598-615. doi: 10.1016/j.jaccao.2022.11.011. eCollection 2022 Dec.
7
HDL and ASCVD.高密度脂蛋白胆固醇与 ASCVD。
Adv Exp Med Biol. 2022;1377:109-118. doi: 10.1007/978-981-19-1592-5_8.
8
Inducible co-stimulator inhibits lipid phagocytosis of human aortic smooth muscle cells by down-regulating CD36 expression.可诱导共刺激分子通过下调CD36表达抑制人主动脉平滑肌细胞的脂质吞噬作用。
J Thorac Dis. 2022 Jan;14(1):147-157. doi: 10.21037/jtd-21-1901.
9
Immune Checkpoint Therapies and Atherosclerosis: Mechanisms and Clinical Implications: JACC State-of-the-Art Review.免疫检查点治疗与动脉粥样硬化:机制与临床意义:美国心脏病学会临床精要综述。
J Am Coll Cardiol. 2022 Feb 15;79(6):577-593. doi: 10.1016/j.jacc.2021.11.048.
10
RNA sequencing of blood in coronary artery disease: involvement of regulatory T cell imbalance.冠心病患者血液中的 RNA 测序:调节性 T 细胞失衡的参与。
BMC Med Genomics. 2021 Sep 3;14(1):216. doi: 10.1186/s12920-021-01062-2.